Journal
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
Volume -, Issue -, Pages -Publisher
ENDOCRINE SOC
DOI: 10.1210/clinem/dgad356
Keywords
PCOS; hyperandrogenism; adipose tissue; fat; metabolic dysfunction; metabolic syndrome; miRNAs; DNA methylation; inflammation; GLUT-4; insulin signaling; adipokines; adiponectin; cytokines; weight loss; diet; exercise; thiazolidinediones; metformin; GLP-1R agonists
Categories
Ask authors/readers for more resources
Polycystic ovary syndrome (PCOS) is a common endocrine disorder affecting 5% to 15% of reproductive-aged women globally, characterized by dysfunction in adipose tissue (AT), leading to metabolic and inflammation abnormalities. Dysregulation in storage capacity, impaired adipogenesis, insulin signaling dysfunction, dysregulated lipolysis, epigenetic dysregulation, and mitochondrial dysfunction are identified mechanisms of AT dysfunction in PCOS. Additional research is urgently needed to further understand and address this important aspect of PCOS.
Purpose Polycystic ovary syndrome (PCOS) is a complex genetic trait and the most common endocrine disorder of women, clinically evident in 5% to 15% of reproductive-aged women globally, with associated cardiometabolic dysfunction. Adipose tissue (AT) dysfunction appears to play an important role in the pathophysiology of PCOS even in patients who do not have excess adiposity. Methods We undertook a systematic review concerning AT dysfunction in PCOS, and prioritized studies that assessed AT function directly. We also explored therapies that targeted AT dysfunction for the treatment of PCOS. Results Various mechanisms of AT dysfunction in PCOS were identified including dysregulation in storage capacity, hypoxia, and hyperplasia; impaired adipogenesis; impaired insulin signaling and glucose transport; dysregulated lipolysis and nonesterified free fatty acids (NEFAs) kinetics; adipokine and cytokine dysregulation and subacute inflammation; epigenetic dysregulation; and mitochondrial dysfunction and endoplasmic reticulum and oxidative stress. Decreased glucose transporter-4 expression and content in adipocytes, leading to decreased insulin-mediated glucose transport in AT, was a consistent abnormality despite no alterations in insulin binding or in IRS/PI3K/Akt signaling. Adiponectin secretion in response to cytokines/chemokines is affected in PCOS compared to controls. Interestingly, epigenetic modulation via DNA methylation and microRNA regulation appears to be important mechanisms underlying AT dysfunction in PCOS. Conclusion AT dysfunction, more than AT distribution and excess adiposity, contributes to the metabolic and inflammation abnormalities of PCOS. Nonetheless, many studies provided contradictory, unclear, or limited data, highlighting the urgent need for additional research in this important field.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available